4.7 Article

A Novel Investigational Fc-Modified Humanized Monoclonal Antibody, Motavizumab-YTE, Has an Extended Half-Life in Healthy Adults

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medicine, Research & Experimental

Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis

Jessie R. Groothuis et al.

ADVANCES IN THERAPY (2011)

Article Pharmacology & Pharmacy

Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences

Weirong Wang et al.

DRUG METABOLISM AND DISPOSITION (2011)

Review Medicine, Research & Experimental

Neonatal Fc receptor and IgG-based therapeutics

Timothy T. Kuo et al.

Article Medicine, General & Internal

The Burden of Respiratory Syncytial Virus Infection in Young Children

Caroline Breese Hall et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Review Immunology

FcRn: the neonatal Fc receptor comes of age

Derry C. Roopenian et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Biochemistry & Molecular Biology

Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)

William F. Dall'Acqua et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)